June 7 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO :
* Aralez announces national U.S. commercial launch of Zontivity
* Has also advanced its goal of ensuring patient access to Zontivity with an out-of-pocket cost competitive to other branded anti-platelet agents
* Aralez Pharmaceuticals Inc says national commercial launch of Zontivity in U.S. will commence this week Source text for Eikon: ID:nPn9QmcNDa Further company coverage: ARZ.TO